Drug-coated balloons and dialysis vascular access: is there light at the end of the tunnel . . .

This commentary uses the negative results of the PAVE (Paclitaxel-coated Balloons and Angioplasty of Arteriovenous Fistulas) study to (i) discuss the role of drug-coated balloons in the armamentarium of therapies for dialysis vascular access stenosis and (ii) suggest a more patient centered, individualized, and precision medicine-based approach for the future care of patients with dialysis vascular access dysfunction.
(Copyright © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.)